GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

GemVax&KAEL Revenue

GemVax&KAEL had revenue of 18.26B KRW in the quarter ending March 31, 2026, with 47.56% growth. This brings the company's revenue in the last twelve months to 87.41B, up 44.89% year-over-year. In the year 2025, GemVax&KAEL had annual revenue of 81.53B with 30.05% growth.

• Revenue (ttm): 87.41B
• Revenue Growth: +44.89%
• P/S Ratio: 6.70
• Revenue / Employee: 480.30M
• Employees: 182
• Market Cap: 585.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	81.53B	18.84B	30.05%
Dec 31, 2024	62.69B	-9.52B	-13.18%
Dec 31, 2023	72.21B	-3.60B	-4.74%
Dec 31, 2022	75.80B	15.43B	25.56%
Dec 31, 2021	60.37B	-5.29B	-8.06%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error